Cambium Networks Corp 8-K/A

What Happened
Cambium Networks Corporation announced in an 8‑K that on March 25, 2026 it received a written notice from a Nasdaq Hearings Panel determining to delist the company's ordinary shares for failure to comply with the Panel’s Decision. Nasdaq will suspend trading in Cambium’s shares at the open on March 27, 2026. The company said it is considering an appeal to the Nasdaq Listing and Hearing Review Council under Nasdaq Listing Rule 5820(a), but an appeal would not prevent the trading suspension.

Key Details

• Nasdaq trading suspension: effective at the open of trading on March 27, 2026.
• Post‑suspension market plans: the company expects shares to initially move to the OTC Pink Limited tier and then to the OTC Expert Market under ticker "CMBM."
• Appeal option: Cambium may request review by the Nasdaq Listing and Hearing Review Council; such a request does not stay the suspension.
• Disclosure: Cambium issued a press release on March 26, 2026 announcing the delist determination (Exhibit 99.1 to the 8‑K).

Why It Matters
A Nasdaq delisting and suspension of trading can materially affect liquidity and the market price of Cambium shares. Moving to OTC Pink or the Expert Market typically reduces trading volume and can make it harder for shareholders to buy or sell shares. The company’s ability to appeal the delisting is noted in the filing, but the appeal does not stop the immediate suspension, and there is no assurance a quoted OTC market will be sustained. Investors should be aware of the change in trading venue and the potential impact on share liquidity and price.